In this study, we examined the effect of pre-treatment using first-line chemotherapies on MSC-TRAIL-induced inhibition in non-small cell lung cancers (NSCLCs)–derived CSCs. This evidence concerns the gene TNFSF10 and non-small cell lung carcinoma.